Literature DB >> 19343059

Effects of lysophosphatidylcholine on beta-amyloid-induced neuronal apoptosis.

Zhen-xia Qin1, Hui-yan Zhu, Ying-he Hu.   

Abstract

AIM: We have investigated the effects of lysophosphatidylcholine (LPC), a product of lipid peroxidation, on Abeta(1-42)-induced SH-SY5Y cell apoptosis.
METHODS: The viability of cultured SH-SY5Y cells was measured using a CCK-8 kit. Apoptosis was determined by Chip-based flow cytometric assay. The mRNA transcription of Bcl-2, Bax, and caspase-3 were detected by using reverse transcription and real-time quantitative PCR and the protein levels of Bax and caspase-3 were analyzed by Western blotting. The cytosolic calcium concentration of SH-SY5Y cells was tested by calcium influx assay. G2A expression in SH-SY5Y cells was silenced by small interfering RNA.
RESULTS: Long-term exposure of SH-SY5Y cells to LPC augmented the neurotoxicity of Abeta(1-42). Furthermore, after LPC treatment, the Bax/Bcl-x(L) ratio and the expression levels, as well as the activity of caspase-3 were, elevated, whereas the expression level of TRAF1 was reduced. Because LPC was reported to be a specific ligand for the orphan G-protein coupled receptor, G2A, we investigated LPC-mediated changes in calcium levels in SH-SY5Y cells. Our results demonstrated that LPC can enhance the Abeta(1-42)-induced elevation of intracellular calcium. Interestingly, Abeta(1-42) significantly increased the expression of G2A in SH-SY5Y cells, whereas knockdown of G2A using siRNA reduced the effects of LPC on Abeta(1-42)-induced neurotoxicity.
CONCLUSION: The effects of LPC on Abeta(1-42)-induced apoptosis may occur through the signal pathways of the orphan G-protein coupled receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343059      PMCID: PMC4002278          DOI: 10.1038/aps.2009.25

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  37 in total

Review 1.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

2.  Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

Authors:  J H Kabarowski; K Zhu; L Q Le; O N Witte; Y Xu
Journal:  Science       Date:  2001-07-27       Impact factor: 47.728

3.  Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

Authors:  H Misonou; M Morishima-Kawashima; Y Ihara
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

4.  The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis.

Authors:  Phoebe Lin; Richard D Ye
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

5.  Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death.

Authors:  Rena Li; Libang Yang; Kristina Lindholm; Yoshihiro Konishi; Xu Yue; Harald Hampel; Dai Zhang; Yong Shen
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 7.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

Authors:  D Allan Butterfield; Alessandra Castegna; Christopher M Lauderback; Jennifer Drake
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

8.  Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death.

Authors:  Jung-Hee Jang; Okezie I Aruoma; Ling-Sun Jen; Hae Young Chung; Young-Joon Surh
Journal:  Free Radic Biol Med       Date:  2004-02-01       Impact factor: 7.376

Review 9.  Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.

Authors:  Khalid Iqbal; Alejandra del C Alonso; Ezzat El-Akkad; Cheng-Xin Gong; Niloufar Haque; Sabiha Khatoon; Jin-Jing Pei; Hitoshi Tanimukai; Ichiro Tsujio; Jian-Zhi Wang; Inge Grundke-Iqba
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

Review 10.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

View more
  6 in total

1.  Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.

Authors:  Tianrong Li; Weidong Tang; Li Zhang
Journal:  Neurol Sci       Date:  2016-05-04       Impact factor: 3.307

2.  Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.

Authors:  Kyle Farmer; Catherine A Smith; Shawn Hayley; Jeffrey Smith
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

3.  Troxerutin protects hippocampal neurons against amyloid beta-induced oxidative stress and apoptosis.

Authors:  Fereshteh Farajdokht; Mohammad Amani; Fariba Mirzaei Bavil; Alireza Alihemmati; Gisou Mohaddes; Shirin Babri
Journal:  EXCLI J       Date:  2017-08-09       Impact factor: 4.068

Review 4.  An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.

Authors:  Shi-Hui Law; Mei-Lin Chan; Gopal K Marathe; Farzana Parveen; Chu-Huang Chen; Liang-Yin Ke
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

5.  Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics.

Authors:  Emmanuelle Lecommandeur; Maria Begoña Cachón-González; Susannah Boddie; Ben D McNally; Andrew W Nicholls; Timothy M Cox; Julian L Griffin
Journal:  Metabolites       Date:  2020-12-30

Review 6.  Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain.

Authors:  Jinxuan Ren; Jiaqi Lin; Lina Yu; Min Yan
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.